Insulin lispro protamine(Eli Lilly Nederland Bv)

精蛋白锌重组赖脯胰岛素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin lispro protamine(Eli Lilly Nederland Bv)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2013/02/04
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLilly Suzhou Pharmaceutical Co LtdLilly France SasEli Lilly Nederland BV
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A